Evidence of gestational heroin exposure by comparative analysis of fetal and maternal body Fluids, tissues, and hair in a heroin-related death

Journal of Analytical Toxicology

Volumn 22, Issue 4, 1998, Pages 296-298

  Iwersen, Stefanie ^a   Schmoldt, Achim ^a   Schulz, Friedrich ^a   Püschel, Klaus ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; MORPHINE; MORPHINE 6 ACETATE;

ADULT; ARTICLE; BODY FLUID; CASE REPORT; DEATH; DRUG ABUSE; FEMALE; FETUS; FETUS BLOOD; HAIR ANALYSIS; HUMAN; HUMAN TISSUE; MATERNAL BLOOD; PRENATAL DRUG EXPOSURE; TISSUE LEVEL;

EID: 0031828895     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/22.4.296     Document Type: Article

References (18)

1. T.M. Doberczak, S.R. Kandall, and P. Friedmann. Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Am. J. Obstet. Gynecol. 81:936-940 (1993).
2. M. Behnke and F.D. Eyler. The consequences of prenatal substance use for the developing fetus, newborn, and young child. Int. J. Addict 28(13): 1341-1391 (1993).
3. L. Jain, W. Meyer, C. Moore, I. Tebbett, D. Gauthier, and D. Vidyasagar. Detection of fetal cocaine exposure by analysis of amniotic fluid. Obstet. Gynecol. 81: 787-790 (1993).
4. E.M. Ostrea, S. Brady, A.L. Gause, A.L. Raymundo, and M. Stevens. Drug screening in newborns by meconium analysis: a large scale, prospective, epidemiologic study. J. Pediatr. 895: 107-113 (1992).
5. C. Moore, D. Dempsey, D. Deitermann, D. Lewis, and J. Leikin. Fetal cocaine exposure: analysis of vernix caseosa. J. Anal. Toxicol. 20: 509-511 (1996).
6. J. Klein, R. Forman, C. Eliopoulos, and G. Koren. A method for simultaneous measurement of cocaine and nicotine in neonatal hair. Ther. Drug. Monit. 16: 67-70 (1994).
7. P. Kintz and P. Mangin. Evidence of gestational heroin or nicotine exposure by analysis of fetal hair. Forensic Sci. Int. 63: 99-104 (1993).
8. L. Pötsch. A discourse on human hair fibers reflections on the conservation of drug molecues. Int. J. Legal Med. 108: 285-293 (1996).
9. D.W. Smith and T.G. Bradley. Scalp hair patterning as a clue to early fetal brain development. J. Pediatr. 83: 374-380 (1973).
10. W. Vycudilik. Vergleichende Morphinbestimmung an Gehirnteilen mittels kombinierter GC/MS. Eine Möglichkeit zur Eingrenzung der Überlebenszeit. Z. Rechtsmed. 99:263-272 (1988).
11. S. Mouton. Drugs used in pregnancy and their placental transfer. In Placental Pharmacology. B.V. Rama Sastry, Ed. CRC Press, Boca Raton, FL, 1996, pp 67-87.
12. P. Hartvig, B.S. Lindberg, A. Lilja, H. Lundqvist, B. Langstrom, and A. Rane. Positron tomography in studies on fetomaternal disposition of opioids. Dev. Pharmacol. Ther. 12(2): 74-80 (1989).
13. G. Skopp, L. Pötsch, and R. Aderjahn. Experimental investigations on hair fibers as diffusion bridges and opiates as solutes in solution. J. Forensic Sci. 41 (1): 117-120 (1996).
14. B.A. Goldberger, Y.H. Caplan, T. Maguire, and E.J. Cone. Testing human hair for drugs of abuse. III. Identification of heroin and 6-acteylmorphine as indicators of heroin use. J. Anal. Toxicol. 15: 226-231 (1991).
15. E. Gerdin, A. Rane, and B. Lindberg. Transplacental transfer of morphine in man. J. Perinat. Med. 18: 305-312 (1990).
16. G.M. Pacifici, L. Saewe, L. Kager, and A. Rane. Morphine glucuronidation in human, fetal and adult liver. Eur. J. Clin. Pharmacol. 22: 553-558 (1982).
17. M.W. Coughtrie, B. Burchell, J.E.A. Leakey, and R. Hume. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosytransferase isoenzyme in rat and human liver microsomes. Mol. Pharmacol. 34: 729-735 (1988).
18. M.R. Juchau. Drug biotransformation reactions in the placenta. In Perinatal Pharmacology and Therapeutics. B.L. Mirkin, Ed. Academic Press, Inc., London, U.K., 1976.